Publication | Open Access
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
18
Citations
21
References
2023
Year
ClinicalTrials.gov NCT03967925. Registered on May 30, 2019.
| Year | Citations | |
|---|---|---|
Page 1
Page 1